S. Goldsmith

发表

Radiotracers for low density lipoprotein biodistribution studies in vivo: technetium-99m low density lipoprotein versus radioiodinated low density lipoprotein preparations.

V. Fuster, S. Vallabhajosula, J. Badimón, 1988, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Possible axonal regrowth in late recovery from the minimally conscious state.

Bruce D. McCandliss, N. Schiff, H. Voss, 2006, The Journal of clinical investigation.

To ablate or not to ablate: issues and evidence involved in 131I ablation of residual thyroid tissue in patients with differentiated thyroid carcinoma.

S. Goldsmith, 2011, Seminars in nuclear medicine.

Peripheral Facial Nerve Palsy after High-Dose Radioiodine Therapy in Patients with Papillary Thyroid Carcinoma

Steven P. Larson, S. Larson, S. Goldsmith, 1994, Annals of Internal Medicine.

Radioimmunoassay: review of basic principles.

S. Goldsmith, Stanley J. Goldsmith, Stanley J. Goldsmith, 1975, Seminars in nuclear medicine.

PET in the assessment of therapy response in patients with carcinoma of the head and neck and of the esophagus.

Lale Kostakoglu, L. Kostakoglu, S. Goldsmith, 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Radioimmunotherapy of Metastatic Prostate Cancer with ¹⁷⁷Lu-DOTAhuJ591 Anti Prostate Specific Membrane Antigen Specific Monoclonal Antibody.

S. Vallabhajosula, N. Bander, S. Tagawa, 2016, Current radiopharmaceuticals.

The SNM Practice Guideline for Somatostatin Receptor Scintigraphy 2.0*

E. Krenning, S. Goldsmith, G. Dillehay, 2011, The Journal of Nuclear Medicine Technology.

Phase 1/2 study of fractionated dose lutetium‐177–labeled anti–prostate‐specific membrane antigen monoclonal antibody J591 (177Lu‐J591) for metastatic castration‐resistant prostate cancer

H. Beltran, S. Vallabhajosula, N. Bander, 2019, Cancer.

Noninvasive imaging of 99mtechnetium-labeled low density lipoprotein uptake by tendon xanthomas in hypercholesterolemic patients.

S. Vallabhajosula, H. Ginsberg, S. Goldsmith, 1990, Arteriosclerosis.

Evaluation of WHO criteria for diagnosis of polycythemia vera: a prospective analysis.

R. Silver, S. Goldsmith, A. Orazi, 2013, Blood.

Noninvasive detection of left ventricular dysfunction with a portable electrocardiographic gated scintillation probe device.

R. Gorlin, L. Teichholz, S. Goldsmith, 1981, The American journal of cardiology.

Imaging Multidrug Resistance in Hematological Malignancies

L. Kostakoglu, S. Goldsmith, 2001, Hematology.

Assessing collateral cerebral perfusion with technetium-99m-HMPAO SPECT during temporary internal carotid artery occlusion.

S. Goldsmith, C. Palestro, M. Afriyie, 1993, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Clinical use of monoclonal antibody HuJ591 therapy: targeting prostate specific membrane antigen.

N. Bander, M. Milowsky, L. Kostakoglu, 2003, The Journal of urology.

The SNMMI Practice Guideline for Therapy of Thyroid Disease with 131I 3.0*

J. Anthony Parker, Abass Alavi, Stanley J. Goldsmith, 2012, The Journal of Nuclear Medicine.

Targeted Radionuclide Therapy: A Historical and Personal Review.

S. Goldsmith, 2020, Seminars in nuclear medicine.

Radioiodine Therapy in Differentiated Thyroid Carcinoma

S. Goldsmith, J. Mihailovič, J. Mihailovic, 2019, The Thyroid and Its Diseases.

Radioactive Iodine Therapy of Differentiated Thyroid Carcinoma: Redesigning the Paradigm

S. Goldsmith, 2016, Molecular imaging and radionuclide therapy.

67Ga-transferrin and 67Ga-lactoferrin binding to tumor cells: Specific versus nonspecific glycoprotein-cell interaction

S. Vallabhajosula, S. Goldsmith, T. Ohnuma, 2004, European Journal of Nuclear Medicine.

Can exercise electrocardiography and thallium-201 myocardial imaging exclude the diagnosis of coronary artery disease? Bayesian analysis of the clinical limits of exclusion and indications for coronary angiography.

A. Pichard, R. Gorlin, M. Herman, 1982, The American journal of cardiology.

Biologic bypass with the use of adenovirus-mediated gene transfer of the complementary deoxyribonucleic acid for vascular endothelial growth factor 121 improves myocardial perfusion and function in the ischemic porcine heart.

R. Crystal, R. Devereux, N. Hackett, 1998, The Journal of thoracic and cardiovascular surgery.

Investigation of the role of the base in the synthesis of [18F]FLT.

S. Vallabhajosula, D. Ballon, S. Goldsmith, 2007, Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine.

Bone SPECT in patients with persistent back pain after lumbar spine surgery.

S. Goldsmith, J. Lusins, E. Danielski, 1989, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Radionuclide diagnosis of vertebral osteomyelitis: indium-111-leukocyte and technetium-99m-methylene diphosphonate bone scintigraphy.

S. Vallabhajosula, S. Goldsmith, C. Palestro, 1991, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Lymphoma imaging: nuclear medicine.

L. Kostakoglu, S. Goldsmith, 2006, Cancer treatment and research.

Effect of blood-brain barrier and blood-tumor barrier modification on central nervous system liposomal uptake.

S. Vallabhajosula, R. Zappulla, S. Goldsmith, 1993, Cancer investigation.

Prediction of myelotoxicity based on bone marrow radiation-absorbed dose: radioimmunotherapy studies using 90Y- and 177Lu-labeled J591 antibodies specific for prostate-specific membrane antigen.

S. Vallabhajosula, N. Bander, K. Hamacher, 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

The SNM Practice Guideline for Therapy of Thyroid Disease with 131 I 3.0*

A. Alavi, H. Jadvar, W. Martin, 2011 .

Phase II Study of Lutetium-177–Labeled Anti-Prostate-Specific Membrane Antigen Monoclonal Antibody J591 for Metastatic Castration-Resistant Prostate Cancer

Stanley J. Goldsmith, Shankar Vallabhajosula, Howard I. Scher, 2013, Clinical Cancer Research.

Bone Marrow Recovery and Subsequent Chemotherapy Following Radiolabeled Anti-Prostate-Specific Membrane Antigen Monoclonal Antibody J591 in Men with Metastatic Castration-Resistant Prostate Cancer

S. Vallabhajosula, N. Bander, B. Robinson, 2013, Front. Oncol..

Targeted systemic therapy of prostate cancer with a monoclonal antibody to prostate-specific membrane antigen.

N. Bander, M. Milowsky, L. Kostakoglu, 2003, Seminars in oncology.

Pharmacokinetics and biodistribution of 111In- and 177Lu-labeled J591 antibody specific for prostate-specific membrane antigen: prediction of 90Y-J591 radiation dosimetry based on 111In or 177Lu?

S. Vallabhajosula, N. Bander, K. Hamacher, 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Phase II trial of 177Lutetium radiolabeled anti-prostate-specific membrane antigen (PSMA) monoclonal antibody J591 (177Lu- J591) in patients (pts) with metastatic castrate-resistant prostate cancer (metCRPC)

S. Vallabhajosula, N. Bander, M. Morris, 2008 .

Bone marrow recovery and subsequent chemotherapy following radiolabeled anti-prostate-specific membrane antigen (PSMA) monoclonal antibody J591 in patients (pts) with metastatic castration-resistant prostate cancer (metCRPC).

S. Vallabhajosula, N. Bander, S. Tagawa, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase I dose-escalation study of docetaxel/predisone and fractionated 177Lu-J591 for metastatic castrate-resistant prostate cancer (metCRPC).

H. Beltran, S. Vallabhajosula, N. Bander, 2010 .

A randomized phase II trial of 177lu radiolabeled monoclonal antibody J591 (177Lu-J591) and ketoconazole in patients (pts) with high-risk castrate biochemically relapsed prostate cancer (PC) after local therapy.

H. Beltran, S. Vallabhajosula, J. Osborne, 2010 .

Phase I trial of fractionated-dose 177lutetium radiolabeled anti-prostate-specific membrane antigen (PSMA) monoclonal antibody J591 (177Lu-J591) in patients (pts) with metastatic castration-resistant prostate cancer (metCRPC).

H. Beltran, S. Vallabhajosula, N. Bander, 2010 .

952 ANTI-PROSTATE SPECIFIC MEMBRANE ANTIGEN (PSMA)-BASED RADIOIMMUNOTHERAPY FOR METASTATIC CASTRATION-RESISTANT PROSTATE CANCER (CRPC): A DECADE OF EXPERIENCE WITH RADIOLABELED (RL)-J591

H. Beltran, S. Vallabhajosula, N. Bander, 2012 .

Nuclear Medicine in the Diagnosis and Management of Colorectal Cancer

L. Kostakoglu, S. Goldsmith, 2002 .

Radionuclide Imaging of Thoracic Malignancies

L. Kostakoglu, S. Goldsmith, C. Palestro, 2005 .

Radionuclide imaging of thoracic malignancies.

L. Kostakoglu, S. Goldsmith, C. Palestro, 2004, Thoracic surgery clinics.

Nuclear oncology : diagnosis and therapy

J. Maublant, S. Goldsmith, I. Khalkhali, 2001 .

Clinical utility of radiolabeled monoclonal antibodies in prostate cancer.

S. Vallabhajosula, N. Bander, M. Milowsky, 2006, Clinical genitourinary cancer.

The value of Ga-67 scintigraphy and F-18 fluorodeoxyglucose positron emission tomography in staging and monitoring the response of lymphoma to treatment.

S. Goldsmith, R. Bar-Shalom, N. Yefremov, 2001, Seminars in nuclear medicine.

Somatostatin-receptor imaging in lymphoma.

H. Macapinlac, S. Goldsmith, J. P. O'Brien, 1995, Seminars in nuclear medicine.

In vitro characterization of radiolabeled monoclonal antibodies specific for the extracellular domain of prostate-specific membrane antigen.

N. Bander, S. Goldsmith, V. Navarro, 2000, Cancer research.

PET-CT fusion imaging in differentiating physiologic from pathologic FDG uptake.

L. Kostakoglu, S. Goldsmith, R. Hardoff, 2004, Radiographics : a review publication of the Radiological Society of North America, Inc.

Multiple myeloma: 18F-FDG-PET/CT and diagnostic imaging.

S. Goldsmith, J. Mihailovič, J. Mihailovic, 2015, Seminars in nuclear medicine.

Extra-articular knee lesion with high fluorodeoxyglucose-uptake on positron emission tomography.

S. Goldsmith, J. Paul, J. Lane, 2013, Bulletin of the Hospital for Joint Disease.

Delayed biliary-to-bowel transit in cholescintigraphy after cholecystokinin treatment.

S. Goldsmith, C. Palestro, C. K. Kim, 1990, Radiology.

NANETS treatment guidelines: well-differentiated neuroendocrine tumors of the stomach and pancreas.

R. Jensen, D. Klimstra, James C Yao, 2010, Pancreas.

Comparison of fluorine‐18 fluorodeoxyglucose positron emission tomography and Ga‐67 scintigraphy in evaluation of lymphoma

J. Leonard, S. Vallabhajosula, L. Kostakoglu, 2002, Cancer.

Update on nuclear medicine imaging of neuroendocrine tumors.

S. Goldsmith, 2009, Future oncology.

The NANETS Consensus Guideline for the Diagnosis and Management of Neuroendocrine Tumors: Well-Differentiated Neuroendocrine Tumors of the Jejunum, Ileum, Appendix, and Cecum

Manal M. Hassan, R. Jensen, C. Nutting, 2010, Pancreas.

Phase 1 study of radiosensitization using bortezomib in patients with relapsed non-Hodgkin lymphoma receiving radioimmunotherapy with 131I-tositumomab

M. Kaminski, J. Leonard, K. Griffith, 2015, Leukemia & lymphoma.

Phase I study of the anti-CD74 monoclonal antibody milatuzumab (hLL1) in patients with previously treated B-cell lymphomas

J. Leonard, S. Ely, S. Goldsmith, 2015, Leukemia & lymphoma.

Nuclear medicine imaging of lung cancer.

L. Kostakoglu, S. Goldsmith, 2000, Radiologic clinics of North America.

Procedure guideline for somatostatin receptor scintigraphy with (111)In-pentetreotide.

E. Krenning, B. Siegel, K. Donohoe, 2001, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Metastatic Human Colonic Carcinoma: Molecular Imaging with PretargetedSPECTandPETina

S. Vallabhajosula, W. Mcbride, D. Goldenberg, 2008 .

Metastatic human colonic carcinoma: molecular imaging with pretargeted SPECT and PET in a mouse model.

S. Vallabhajosula, W. Mcbride, D. Goldenberg, 2008, Radiology.

Low-density lipoprotein (LDL) distribution shown by 99mtechnetium-LDL imaging in patients with myeloproliferative diseases.

S. Vallabhajosula, H. Ginsberg, M. Paidi, 1989, Annals of internal medicine.

Phase II study of lutetium-177 labeled anti-prostate-specific membrane antigen (PSMA) monoclonal antibody J591 for metastatic castration-resistant prostate cancer

Larson, S. Vallabhajosula, N. Bander, 2013 .

Rhenium-186-labeled hydroxyethylidene diphosphonate dosimetry and dosing guidelines for the palliation of skeletal metastases from androgen-independent prostate cancer.

S. Larson, H. Scher, S. Goldsmith, 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

Flare on bone scintigraphy following Taxol chemotherapy for metastatic breast cancer.

S J Goldsmith, A M Scott, S. Larson, 1994, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Invasion from Mars

S. Goldsmith, 1995 .

Current status of radiolabeled peptides in nuclear medicine diagnosis and therapy.

S. Goldsmith, 2002, Seminars in nuclear medicine.

Visualization of myocardial metastasis of carcinoid tumor by indium-111-pentetreotide.

S. Larson, H. Macapinlac, M. Imbriaco, 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Non-specific binding of transferrin and lactoferrin to polystyrene culture tubes: Role of the radioligand

S. Vallabhajosula, S. Goldsmith, 2004, European Journal of Nuclear Medicine.

Radiolabeled monoclonal antibodies specific to the extracellular domain of prostate-specific membrane antigen: preclinical studies in nude mice bearing LNCaP human prostate tumor.

S. Vallabhajosula, N. Bander, S. Goldsmith, 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Radioimmunotherapy of prostate cancer in human xenografts using monoclonal antibodies specific to prostate specific membrane antigen (PSMA): Studies in nude mice

S. Vallabhajosula, N. Bander, S. Goldsmith, 2004, The Prostate.

Antibody to Prostate-Specific Membrane Antigen, in Patients With Androgen-Independent Prostate Cancer

S. Vallabhajosula, N. Bander, M. Milowsky, 2005 .

Extrathyroidal extension is not all equal: Implications of macroscopic versus microscopic extent in papillary thyroid carcinoma.

T. Fahey, S. Goldsmith, P. Wagner, 2008, Surgery.

Gated blood pool scintigraphic monitoring of doxorubicin cardiomyopathy: comparison of camera and computerized probe results in 101 patients.

S. Goldsmith, S. Horowitz, A. Strashun, 1986, Journal of the American College of Cardiology.

Complimentary roles of cardiac ultrasound and cardiovascular nuclear medicine.

L. Teichholz, S. Goldsmith, R. Patterson, 1980, Seminars in nuclear medicine.

Indium-111 platelet kinetics in normal human subjects: tropolone versus oxine methods.

V. Fuster, J. Machac, S. Vallabhajosula, 1986, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Accuracy and precision of regional multiharmonic Fourier analysis of gated blood-pool images.

J. Machac, S. Goldsmith, S. Horowitz, 1984, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Value of blood-pool subtraction in cardiac indium-111-labeled platelet imaging.

V. Fuster, J. Machac, S. Vallabhajosula, 1989, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Peptides in Biomedical Sciences: Principles and Practice

S. Vallabhajosula, R. Lees, A. M. Lees, 1994 .

Early assessment of radiation response using a novel functional imaging modality -- [18F]fluorocholine PET (FCH-PET): a pilot study.

S. Vallabhajosula, K. Chao, J. Osborne, 2012, Discovery medicine.

Radioimmunotherapy of Prostate Cancer Using 90Y- and 177Lu-Labeled J591 Monoclonal Antibodies: Effect of Multiple Treatments on Myelotoxicity

S. Vallabhajosula, N. Bander, L. Kostakoglu, 2005, Clinical Cancer Research.

Phase I dose-escalation study of fractionated dose 177Lu-PSMA-617 for progressive metastatic castration resistant prostate cancer (mCRPC).

H. Beltran, S. Vallabhajosula, N. Bander, 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

Phase I trial of docetaxel/prednisone plus fractionated dose radiolabeled anti-prostate-specific membrane antigen (PSMA) monoclonal antibody 177lu-J591 in patients with metastatic, castration-resistant prostate cancer (mCRPC).

H. Beltran, S. Vallabhajosula, N. Bander, 2014 .

The use of technetium-99m sulfur colloid as a marker for experimental venous thrombosis: concise communication.

S. Goldsmith, P. Bardfeld, J. Rand, 1981, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Etoposide Induced Blood-Brain Barrier Disruption in Rats : Duration of Opening and HistolÃ 3 gica ! Sequelae 1

E. Feuer, R. Zappulla, S. Goldsmith, 2006 .

Reduced Bone Mass in Women With Premenstrual Syndrome

S. Goldsmith, J. Alvir, S. Thys-Jacobs, 1995 .

Phase 1 Study of High-Specific-Activity I-131 MIBG for Metastatic and/or Recurrent Pheochromocytoma or Paraganglioma

N. Stambler, S. Goldsmith, D. Pryma, 2018, The Journal of clinical endocrinology and metabolism.

Appearance of acute gouty arthritis on indium-111-labeled leukocyte scintigraphy.

S. Goldsmith, C. Palestro, C. Kim, 1990, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Acute effects of radiation therapy on indium-111-labeled leukocyte uptake in bone marrow.

S. Goldsmith, C. Palestro, C. K. Kim, 1989, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Imaging of lymphomas

L. Kostakoglu, S. Goldsmith, M. Coleman, 2006 .

Unusual F-18 choline uptake in penile metastasis from prostate cancer.

J. Fettich, B. Kragelj, S. Goldsmith, 2012, Clinical nuclear medicine.

Septal myocardial perfusion imaging with thallium-201 in the diagnosis of proximal left anterior descending coronary artery disease.

A. Pichard, R. Gorlin, M. Herman, 1981, American Heart Journal.

Gaucher's disease type 1: assessment of bone involvement by CT and scintigraphy.

G. Hermann, R. Desnick, J. Goldblatt, 1986, AJR. American journal of roentgenology.

Isolated Splenic Metastasis from Rectal Carcinoma: A Rare Occurrence

R. Yantiss, T. Fahey, S. Goldsmith, 2011, Case Reports in Oncology.

FDG‐PET after 1 cycle of therapy predicts outcome in diffuse large cell lymphoma and classic Hodgkin disease

J. Leonard, P. Christos, L. Kostakoglu, 2006, Cancer.

Subsequent therapy can be administered after tositumomab and iodine I‐131 tositumomab for non‐Hodgkin lymphoma

J. Leonard, S. Vallabhajosula, L. Kostakoglu, 2006, Cancer.

Chemistry and biological behavior of samarium-153 and rhenium-186-labeled hydroxyapatite particles: potential radiopharmaceuticals for radiation synovectomy.

S. Vallabhajosula, S. Goldsmith, A. Tofe, 1993, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Targeted Radionuclide Therapy of Prostate Cancer

S. Vallabhajosula, N. Bander, S. Tagawa, 2013 .

Improving insight into radiobiology and radionuclide therapy.

S. Goldsmith, 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Determination of immunoreactive fraction of radiolabeled monoclonal antibodies: what is an appropriate method?

S. Vallabhajosula, N. Bander, K. Hamacher, 2004, Cancer biotherapy & radiopharmaceuticals.

177Lu‐DOTA‐HuJ591: A new radiolabeled monoclonal antibody (MAb) for targeted therapy of prostate cancer

S. Vallabhajosula, N. Bander, S. Goldsmith, 2001 .

Specificity and sensitivity of distinctive chest radiographic and/or 67Ga images in the noninvasive diagnosis of sarcoidosis.

R. P. Spencer, S. Sulavik, S. Goldsmith, 1993, Chest.

Radioimmunotherapy of Prostate Carcinoma

S. Vallabhajosula, N. Bander, S. Tagawa, 2013 .

Radial and vertebral bone density in white and black women: evidence for racial differences in premenopausal bone homeostasis.

D. Meier, S. Goldsmith, M. Luckey, 1989, The Journal of clinical endocrinology and metabolism.

Tositumomab and iodine I 131 tositumomab: Efficacy and safety in 141 patients (pts) with previously untreated low-grade (LG) non-Hodgkin's lymphoma (NHL)

M. Kaminski, J. Leonard, R. Wahl, 2005 .

PET predicts prognosis after 1 cycle of chemotherapy in aggressive lymphoma and Hodgkin's disease.

J. Leonard, L. Kostakoglu, S. Goldsmith, 2002, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

The utility of monoclonal antibodies in the imaging of prostate cancer.

S. Vallabhajosula, M. Milowsky, L. Kostakoglu, 2002, Seminars in urologic oncology.

Physiological influences on perfusion imaging in transient myocardial ischaemia: importance of early distribution of thallium-201.

S. Goldsmith, R. Patterson, S. Horowitz, 1982, Cardiovascular research.

Total-hip arthroplasty: periprosthetic indium-111-labeled leukocyte activity and complementary technetium-99m-sulfur colloid imaging in suspected infection.

S. Goldsmith, C. Palestro, A. J. Swyer, 1990, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Radioimmunotherapy of lymphoma: Bexxar and Zevalin.

S. Goldsmith, 2010, Seminars in nuclear medicine.

SPECT and Lumbar MRI in Back Pain with Emphasis on Changes in End Plates in Association with Disc Degeneration

S. Goldsmith, J. Lusins, A. Cicoria, 1998, Journal of neuroimaging : official journal of the American Society of Neuroimaging.

In vivo stability of ferric hydroxide macroaggregates (FHMA). Is it a suitable carrier for radionuclides used in synovectomy?

S. Vallabhajosula, S. Goldsmith, M. Chinol, 1990, International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology.

Nuclear Medicine Therapy

S. Goldsmith, C. Aktolun, 2019, Springer International Publishing.

Diagnosis of Musculoskeletal Infection Using Combined In‐111 Labeled Leukocyte and Tc‐99m SC Marrow Imaging

S. Goldsmith, C. Palestro, C. Kim, 1992, Clinical nuclear medicine.

Bremsstrahlung radiation exposure from pure β-ray emitters

S. Goldsmith, B. Binkert, P. Zanzonico, 1999 .

Pneumocystis carinii pneumonia studied by gallium-67 scanning.

S. Goldsmith, L. Shane, M. Rosen, 1985, Radiology.

Malignant external otitis: early scintigraphic detection.

S. Goldsmith, A. Strashun, M. Nejatheim, 1984, Radiology.

Role of ln-111 Labeled Leukocyte Scintigraphy in the Diagnosis of Intracerebral Lesions

S. Goldsmith, C. Palestro, C. Kim, 1991, Clinical nuclear medicine.

Detection of abnormalities in febrile AIDS patients with In-111-labeled leukocyte and Ga-67 scintigraphy.

S. Vallabhajosula, S. Goldsmith, C. Palestro, 1989, Radiology.

Nuclear Medicine Practices in the 1950s through the Mid-1970s and Occupational Radiation Doses to Technologists from Diagnostic Radioisotope Procedures

F. Mettler, R. Reba, P. Kirchner, 2014, Health physics.

Clinically proven radiopharmaceuticals for infection imaging: mechanisms and applications.

S. Vallabhajosula, S. Goldsmith, 2009, Seminars in nuclear medicine.

Gallium scanning in peritoneal mesothelioma.

S. Goldsmith, R. Armas, 1985, AJR. American journal of roentgenology.

99mTc-low density lipoprotein: intracellularly trapped radiotracer for noninvasive imaging of low density lipoprotein metabolism in vivo.

S J Goldsmith, S. Vallabhajosula, S. Goldsmith, 1990, Seminars in nuclear medicine.

RAD1OCHEMISTRY AND RADIOPHARMACEU11CALS RadiochemicalAnalysisof Tc-99m HumanSerumAlbuminwith High-Pressure LiquidChromatography:ConciseCommunication

S. Vallabhajosula, S. Goldsmith, R. Pollina, 2006 .

(90)Y-clivatuzumab tetraxetan with or without low-dose gemcitabine: A phase Ib study in patients with metastatic pancreatic cancer after two or more prior therapies.

R. Korn, D. V. Von Hoff, M. Lowery, 2015, European journal of cancer.

PET imaging of leptin biodistribution and metabolism in rodents and primates.

T. Muir, S. Vallabhajosula, J. Friedman, 2009, Cell metabolism.

Deconvolution using orthogonal polynomials in nuclear medicine: a method for forming quantitative functional images from kinetic studies.

M. King, S. Goldsmith, P. Stritzke, 1990, IEEE transactions on medical imaging.

Phase I trial of 177lutetium-labeled J591, a monoclonal antibody to prostate-specific membrane antigen, in patients with androgen-independent prostate cancer.

Shankar Vallabhajosula, David M Nanus, Neil H Bander, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase I trial of yttrium-90-labeled anti-prostate-specific membrane antigen monoclonal antibody J591 for androgen-independent prostate cancer.

S. Vallabhajosula, N. Bander, M. Milowsky, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Use of Radiopharmaceuticals in Diagnostic Nuclear Medicine in the United States: 1960–2010

S. Moore, A. Brill, W. Shreeve, 2015, Health physics.

Gallium-67-citrate imaging in nuclear oncology.

S. Larson, A. Scott, H. Macapinlac, 1994, Nuclear medicine and biology.

Gallium-67 uptake after breast and hip augmentation with silicone.

S. Goldsmith, C. Palestro, P. Chau, 1992, Clinical nuclear medicine.

Technetium-99m MDP accumulation in hepatic metastasis from osteogenic sarcoma.

S. Goldsmith, C. Palestro, A. Strashun, 1987, Clinical nuclear medicine.

First-in-Man Evaluation of 2 High-Affinity PSMA-Avid Small Molecules for Imaging Prostate Cancer

William C. Eckelman, James B. Stubbs, Stanley J. Goldsmith, 2013, The Journal of Nuclear Medicine.

Targeting metastatic prostate cancer with radiolabeled monoclonal antibody J591 to the extracellular domain of prostate specific membrane antigen.

S. Vallabhajosula, N. Bander, M. Milowsky, 2003, The Journal of urology.

18F-FDG PET evaluation of the response to therapy for lymphoma and for breast, lung, and colorectal carcinoma.

L. Kostakoglu, S. Goldsmith, 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Vascular targeted therapy with anti-prostate-specific membrane antigen monoclonal antibody J591 in advanced solid tumors.

S. Vallabhajosula, N. Bander, M. Milowsky, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Abbreviated chemotherapy with fludarabine followed by tositumomab and iodine I 131 tositumomab for untreated follicular lymphoma.

J. Leonard, E. Cesarman, S. Vallabhajosula, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Infected knee prosthesis: diagnosis with In-111 leukocyte, Tc-99m sulfur colloid, and Tc-99m MDP imaging.

S. Goldsmith, C. Palestro, C. Kim, 1991, Radiology.

Total-Hip Arthroplasty:PeriprostheticIndium-. 111-Labeled Leukocyte Activityand Complementary Technetium-.99m-Sulfur

S. Goldsmith, C. Palestro, C. Kim, 1990 .

Etoposide-induced blood-brain barrier disruption. Effect of drug compared with that of solvents.

R. Zappulla, S. Goldsmith, M. Spigelman, 1984, Journal of neurosurgery.

Indium-111-labeled leukocyte scintigraphy in hemodialysis access-site infection.

S. Vallabhajosula, S. Goldsmith, C. Palestro, 1990, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Diffuse pulmonary uptake of indium-111-labeled leukocytes in drug-induced pneumonitis.

S. Goldsmith, C. Palestro, M. Padilla, 1992, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

SPECT imaging in the diagnosis of Budd-Chiari syndrome.

S. Goldsmith, C. Palestro, C. K. Kim, 1990, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Cisternography and CT Scanning with 111In-DTPA in Evaluation of Posterior Fossa Arachnoid Cysts

S. Goldsmith, J. Lusins, M. Sorek, 1979, Clinical nuclear medicine.

PET/CT Imaging and Radioimmunotherapy of Prostate Cancer.

P. Choyke, B. Turkbey, S. Tagawa, 2011, Seminars in nuclear medicine.

Fractionated radioimmunotherapy with 90Y‐clivatuzumab tetraxetan and low‐dose gemcitabine is active in advanced pancreatic cancer

T. Bekaii-Saab, D. Goldenberg, S. Goldsmith, 2012, Cancer.

99mTc-MIP-1404 Planar and SPECT scan: Imaging biomarker of androgen receptor (AR) signaling and prostate specific membrane antigen (PSMA) expression.

J. A. Epstein, S. Vallabhajosula, S. Tagawa, 2016 .

Fluorine-18 fluorodeoxyglucose positron emission tomography in the staging and follow-up of lymphoma: is it time to shift gears?

L. Kostakoglu, S. Goldsmith, 2000, European Journal of Nuclear Medicine.

Gallium scanning in differentiating malignant from benign asbestos-related pleural disease.

S. Goldsmith, A. Teirstein, P. Chahinian, 1986, American journal of industrial medicine.

Tositumomab and iodine-131 tositumomab produces durable complete remissions in a subset of heavily pretreated patients with low-grade and transformed non-Hodgkin's lymphomas.

J. Vose, A. Zelenetz, M. Kaminski, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

SPECT evaluation of lumbar spondylolysis and spondylolisthesis.

J. Elting, S. Goldsmith, J. Lusins, 1994, Spine.

Anti–prostate‐Specific membrane antigen‐based radioimmunotherapy for prostate cancer

H. Beltran, S. Vallabhajosula, N. Bander, 2010, Cancer.

Bone Scintigraphy in Pleural Metastases of Osteogenic Sarcoma

S. Goldsmith, C. Palestro, C. Kim, 1990, Clinical nuclear medicine.

Etoposide induced blood-brain barrier disruption in rats: duration of opening and histological sequelae.

E. Feuer, R. Zappulla, S. Goldsmith, 1986, Cancer research.

Positron emission tomography in lymphoma: comparison with computed tomography and Gallium-67 single photon emission computed tomography.

L. Kostakoglu, S. Goldsmith, 2000, Clinical lymphoma.

Radiochemical analysis of Tc-99m human serum albumin with high-pressure liquid chromatography: concise communication.

S. Vallabhajosula, S. Goldsmith, H. Lipszyc, 1982, Journal of Nuclear Medicine.

SPECT/CT Imaging for Prostate Cancer

N. Alazraki, S. Goldsmith, S. C. Bartley, 2016 .

Technetium-99m ECD: a new brain imaging agent: in vivo kinetics and biodistribution studies in normal human subjects.

M G Stabin, S J Goldsmith, S. Vallabhajosula, 1989, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Hodgkin’s Disease and Lymphomas

L. Kostakoglu, S. Goldsmith, M. Coleman, 2007 .

Gallium Scintigraphy in Bone Infarction: Correlation with Bone Imaging

S. Goldsmith, R. Armas, 1984, Clinical nuclear medicine.

Extrapulmonary Sites of Radiogallium Accumulation in Sarcoidosis

R. P. Spencer, S. Sulavik, S. Goldsmith, 1990, Clinical nuclear medicine.

Can noninvasive exercise test criteria identify patients with left main or 3-vessel coronary disease after a first myocardial infarction?

A. Pichard, R. Gorlin, M. Herman, 1983, The American journal of cardiology.

Studies of the hepatocellular uptake of the hepatobiliary scintiscanning agent 99mTc-DISIDA.

S. Vallabhajosula, S. Goldsmith, P. Berk, 1986, Journal of hepatology.

Radon update: facts concerning environmental radon: levels, mitigation strategies, dosimetry, effects and guidelines. SNM Committee on Radiobiological Effects of Ionizing Radiation.

K. Kase, A. Brill, S. Goldsmith, 1994, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Amyloid and metabolic positron emission tomography imaging of cognitively normal adults with Alzheimer's parents

S. Vallabhajosula, L. Mosconi, W. Tsui, 2013, Neurobiology of Aging.

Spectrum of exercise thallium-201 myocardial perfusion imaging in patients with chest pain and normal coronary angiograms.

A. Pichard, R. Gorlin, M. Herman, 1979, The American journal of cardiology.

Low density lipoprotein receptor-independent hepatic uptake of a synthetic, cholesterol-scavenging lipoprotein: implications for the treatment of receptor-deficient atherosclerosis.

S. Vallabhajosula, K. Williams, S. Goldsmith, 1988, Proceedings of the National Academy of Sciences of the United States of America.

The Real Cost of Theoretic Risk Avoidance: The Need to Challenge Unsubstantiated Concerns About 131I Therapy

S. Goldsmith, 2011, The Journal of Nuclear Medicine.

Cyclophosphamide, vincristine, and prednisone followed by tositumomab and iodine-131-tositumomab in patients with untreated low-grade follicular lymphoma: eight-year follow-up of a multicenter phase II study.

M. Kaminski, J. Leonard, S. Goldsmith, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Dose-attenuated radioimmunotherapy with tositumomab and iodine 131 tositumomab in patients with recurrent non-Hodgkin's lymphoma (NHL) and extensive bone marrow involvement

J. Leonard, S. Vallabhajosula, S. Kroll, 2007, Leukemia & lymphoma.

Comparative Physical and Pharmacologic Characteristics of Iodine-131 and Yttrium-90: Implications for Radioimmunotherapy for Patients with Non-Hodgkin's Lymphoma

J. Leonard, S. Goldsmith, J. Siegel, 2003, Cancer investigation.

Radioimmunotherapy of Lymphoma

S. Goldsmith, 2012 .

Clinical applications of fusion imaging in oncology.

G Sgouros, H Kalaigian, M C Graham, 1994, Nuclear medicine and biology.

Less is More: The Impact of Multidisciplinary Thyroid Conference on the Treatment of Well-Differentiated Thyroid Carcinoma

T. Fahey, P. Christos, S. Goldsmith, 2018, World Journal of Surgery.

The role of FDG-PET imaging in the management of lymphoma.

J. Leonard, L. Kostakoglu, S. Goldsmith, 2004, Clinical advances in hematology & oncology : H&O.

99mTc-Pertechnetate Scintigraphy as an Aid in the Diagnosis of Breast Masses1

S. Goldsmith, E. Cancroft, 1973 .

SNM Practice Guideline for Breast Scintigraphy with Breast-Specific γ-Cameras 1.0*

T. Heston, S. Goldsmith, L. Lanzkowsky, 2010, The Journal of Nuclear Medicine Technology.

Clinical role of FDG PET in evaluation of cancer patients.

Lale Kostakoglu, L. Kostakoglu, S. Goldsmith, 2003, Radiographics : a review publication of the Radiological Society of North America, Inc.

Quantification of valve regurgitation by radionuclide angiography before and after valve replacement surgery.

R. Litwak, R. Gorlin, M. Packer, 1981, The American journal of cardiology.

Effect of source strength and attenuation on dual photon absorptiometry.

D. Meier, S. Goldsmith, P. Stritzke, 1989, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Detection of bony metastases of androgen-independent prostate cancer by PET-FDG.

S. Larson, H. Scher, Jiaju Zhang, 1996, Nuclear medicine and biology.

Multiple extraosseous metastases from osteogenic sarcoma demonstrated on bone scintigraphy.

S. Goldsmith, C. Palestro, A. J. Swyer, 1992, Clinical nuclear medicine.

Quantitative SPECT imaging with Lu-177: A physical phantom evaluation

S. Vallabhajosula, J. Osborne, S. Goldsmith, 2012 .

Intracarotid dehydrocholate infusion: a new method for prolonged reversible blood-brain barrier disruption.

J. Goldberg, R. Zappulla, S. Goldsmith, 1983, Neurosurgery.

Effect of intracarotid etoposide on opening the blood-brain barrier.

J. Goldberg, R. Zappulla, S. Goldsmith, 1984, Cancer drug delivery.

Final results of 2-dose fractionation of 177Lu-J591 for progressive metastatic castration-resistant prostate cancer (mCRPC).

H. Beltran, S. Vallabhajosula, N. Bander, 2016 .

99mTc-Labeled Small-Molecule Inhibitors of Prostate-Specific Membrane Antigen: Pharmacokinetics and Biodistribution Studies in Healthy Subjects and Patients with Metastatic Prostate Cancer

S. Vallabhajosula, J. Osborne, S. Tagawa, 2014, The Journal of Nuclear Medicine.

Comparison of the clearance of technetium-99m MAG3 and iodine-131 OIH.

S. Goldsmith, P. Stritzke, C. K. Kim, 1988, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Receptor imaging: competitive or complementary to antibody imaging?

S J Goldsmith, S. Goldsmith, Stanley J. Goldsmith, 1997, Seminars in nuclear medicine.

Quantification of cardiac conduction abnormalities using segmental vector Fourier analysis of radionuclide gated blood pool scans.

J. Machac, L. Teichholz, S. Goldsmith, 1983, Journal of the American College of Cardiology.

Characterization and automatic identification of ECG conduction abnormalities using segmental multiharmonic fourier analysis of gated blood-pool scintigrams

J. Machac, R. Fagerstrom, S. Goldsmith, 2004, European Journal of Nuclear Medicine.

Thyroid uptake of liquid versus capsule 131I tracers in hyperthyroid patients treated with liquid 131I.

S. Vallabhajosula, S. Goldsmith, D. Becker, 1999, Thyroid : official journal of the American Thyroid Association.

Durable remissions from fludarabine followed by the iodine I-131 tositumomab Bexxar therapeutic regimen for patients with previously untreated follicular non-Hodgkin's lymphoma (NHL).

J. Leonard, S. Kroll, L. Kostakoglu, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Hypocalcemia in metastatic bone disease: metabolic and radionuclide studies of a case.

S. Goldsmith, A. Strashun, G. Pepper, 1984, New York state journal of medicine.

A dose-escalation study of tositumomab and iodine I 131 tositumomab (Bexxar) in pts with previously treated non-Hodgkin's lymphoma (NHL) with > 25% bone marrow involvement.

J. Leonard, S. Kroll, L. Kostakoglu, 2004, Journal of Clinical Oncology.

Systemic biodistribution of radioiodinated interleukin-2 in the rat.

S. Vallabhajosula, R. Zappulla, S. Goldsmith, 1989, Journal of biological response modifiers.

Original Articles TARGETING METASTATIC PROSTATE CANCER WITH RADIOLABELED MONOCLONAL ANTIBODY J591 TO THE EXTRACELLULAR DOMAIN OF PROSTATE SPECIFIC MEMBRANE ANTIGEN

S. Vallabhajosula, N. Bander, M. Milowsky, 2003 .

Phase II Study of Lutetium-177 – Labeled Anti-Prostate-Speci fi c Membrane Antigen Monoclonal Antibody J 591 for Metastatic Castration-Resistant Prostate Cancer

S. Larson, S. Vallabhajosula, N. Bander, 2013 .

177Lu-J591 monoclonal antibody (Lu-J591) therapy in metastatic castrate-resistant prostate cancer (metCRPC): Correlation of antibody-tumor targeting and treatment response

S. Vallabhajosula, N. Bander, S. Tagawa, 2008 .

Imaging Inflammation in a Patient with Epilepsy Due to Focal Cortical Dysplasia

David Silbersweig, Masanori Ichise, Orrin Devinsky, 2013, Journal of neuroimaging : official journal of the American Society of Neuroimaging.

2200 A PHASE 1 PILOT STUDY OF 99MTC-MIP-1404 SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT)/CT IMAGING IN MEN WITH PROSTATE CANCER UNDERGOING RADICAL PROSTATECTOMY

S. Vallabhajosula, J. Osborne, B. Robinson, 2013 .

Nuclear Oncology

W. N. Tauxe, S. Goldsmith, C. Aktolun, 1999, Springer Berlin Heidelberg.

Postoperative Changes on Brain SPECT Imaging After Aneurysmal Subarachnoid Hemorrhage A Potential Pitfall in the Evaluation of Vasospasm

M. Sacher, S. Goldsmith, J. Rosen, 1994, Clinical Nuclear Medicine.

The uterine blush on In-111 labeled leukocyte scintigraphy.

S. Goldsmith, J. Rosen, C. Palestro, 1991, Clinical Nuclear Medicine.

Uterine leiomyomata. Discrepancy between scintigraphic and radiographic images.

S. Goldsmith, C. Palestro, A. J. Swyer, 1990, Clinical nuclear medicine.

Sickle Cell Crisisas Evaluatedfrom Measurementsof Hydroxybutyrate Dehydrogenaseand Myoglobinin Plasma on plasma

S. Goldsmith, P. Bardfeld, E. Radel, 2004 .

Role of nuclear medicine in the evaluation of the solitary pulmonary nodule.

L. Kostakoglu, S. Goldsmith, Stanley J. Goldsmith, 2000, Seminars in ultrasound, CT, and MR.

The role of gallium and labeled leukocyte scintigraphy in the AIDS patient.

S. Goldsmith, C. Palestro, 1995, The quarterly journal of nuclear medicine : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology.

In‐111 Labeled Leukocyte Imaging in a Case of Pseudogout

S. Goldsmith, C. Palestro, 1992, Clinical nuclear medicine.

Unusual scintigraphic findings in a thyroid adenoma.

J. Mechanick, S. Goldsmith, P. Chau, 1993, Journal of Nuclear Medicine.

99m Tc-pertechnetate scintigraphy as an aid in the diagnosis of breast masses.

S. Goldsmith, E. Cancroft, 1973, Radiology.

The SNM Practice Guideline on Breast Scintigraphy

S. Goldsmith, 2010, The Journal of Nuclear Medicine.

Biodistribution, dosimetry, and clinical evaluation of technetium-99m ethyl cysteinate dimer in normal subjects and in patients with chronic cerebral infarction.

I. Mena, B. Holman, P. Rigo, 1989, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

FDG-PET in prediction of splenectomy findings in patients with known or suspected lymphoma

J. Leonard, T. Fahey, R. Elstrom, 2008, Leukemia & lymphoma.